Skip to content
lifestyle.pspl.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cue Biopharma, Inc.
Cue Biopharma Announces 1-for-30 Reverse Stock Split
May 5, 2026
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
May 4, 2026
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
May 3, 2026
Cue Biopharma Announces CEO Transition
May 2, 2026
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
May 2, 2026
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
May 2, 2026
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
April 30, 2026
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
February 17, 2026
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
February 13, 2026
←
Previous Page
1
2